Retaglutide and tirzepatide are groundbreaking GLP-1 receptor agonists gaining recognition as effective treatment options for type 2 diabetes. These medications stimulate insulin secretion from the pancreas, inhibit glucagon release, and slow down gastric emptying, leading to improved glycemic control. Retaglutide is administered intravenously, whi